03.07.2024 08:04:15 - dpa-AFX: *GSK ACQUIRES FULL RIGHTS TO MRNA CANDIDATE VACCINES FOR INFLUENZA AND COVID-19; CUREVAC RECEIVES UP TO EUR 1.45 BLN

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GSK PLC LS-,3125 A3DMB5 Xetra 18,230 17.07.24 17:35:56 +0,350 +1,96% 0,000 0,000 17,825 17,880

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH